Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Molecules/GEMTUZUMAB OZOGAMICIN

GEMTUZUMAB OZOGAMICIN

CHEMBL1201506
Compare

Molecular Identity

GEMTUZUMAB OZOGAMICIN

ChEMBL ID: CHEMBL1201506

Antibody drug conjugateApprovedFirst approved 2000

Mechanism of action: Myeloid cell surface antigen CD33 binding agent

Properties

Molecular Formula
0.00
Molecular Weight
g/mol

Synonyms(11)

CDP-771CMA-676CMC-676GEMTUZUMAB OZOGAMICINGEMTUZUMAB OZOGAMICINAGEMTUZUMAB OZOGAMICINEGEMTUZUMAB OZOGAMICIN (GENETICAL RECOMBINATION)GEMTUZUMAB OZOGAMICIN RECOMBINANTL01XC05MYLOTARGWAY-CMA-676
Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to GEMTUZUMAB OZOGAMICIN

Loading drug network...